What makes our strategy meetings unique?
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our 2022 Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.
Dr. Tao GuoSVP, Head of WuXi Chemistry – IDSU WuXi AppTec
Andreas SchoopsHead of Medicinal Chemistry WuXi AppTec
Greg MakaraCEO ChemPass
Onur AtasoyluDirector, Head of Computational Chemistry Incyte
Matt BursavichVice President, Head of Chemical Sciences Morphic Therapeutic
Heather CarlsonVice President Chemical Data Sciences Odyssey Therapeutics
Richard HeidebrechtVice President and R&D Glycologix
Jason ImbriglioVice President, Head of Discovery Chemistry Roivant Discovery
Kevin KreutterVP Drug Discovery Empress Therapeutics
Stephanos LoannidisEVP Drug Discovery Exo Therapeutics
Kristen MarinoSenior Scientist II, Computational Chemistry Cellarity
Andrew McRinerVice President, Head of Drug Discovery Auron Therapeutics
Benoit MoreauRemix Therapeutics
Robb NicewongerSenior Director, Medicinal Chemistry Cellarity
Ed OlhavaSenior Vice President, Preclinical Development IFM Therapeutics
Lewis PenningtonSenior Director. Head of Platform Chemistry Kymera Therapeutics
Nisha PerezSenior Director, Head of DMPK ROME Therapeutics
Jennifer PetterFounder & CSO Arrakis Therapeutics
Daniel J. PriceExecutive Director, Head of Computational Chemistry Nimbus Therapeutics
Aimee UseraVice President Chemistry Odyssey Therapeutics
See the full agenda and facilitator line-upDownload the strategy meeting brochure for full details
Who Should Attend the Event?
Chief Executive Officers
Executive Vice Presidents
Hit and Lead Chemist
Small/Large Molecules Chemist
Drug Discovery or Drug Development
See Which Topics Are Discussed at the Strategy Meeting
Advantages and Limitations in Targeting RNA with Small Molecules
Strategy and Implementation for Innovative and Emerging Modalities Drug Discovery WUXI APPTEC
Hit Identification Technologies and Cracking Undruggable Targets – Which Technology to Choose? WUXI APPTEC
Reasons To Attend the Strategy Meeting
Discussions on the advancements in targeted protein degradation and pushing past its boundaries.
Leveraging Artificial Intelligence and Machine Learning in accelerating the development of new drugs
Discuss approaches to further understand the interactions of undruggable targets and different Protein Degraders such as PROTACs, Molecular Glues, etc
Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more
Press play to hear what your colleagues had to say…
Become an official strategy meeting partnerWhatever your business needs, we can help. Get in touch for partnering opportunities
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.